| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $97,007,879 ) (Continued on the next page) |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01HL157166 | Are Interventions Supporting Physical ACtivity modified by the Environment (InSPACE)? | 001 | 3 | NIH | 5/3/2023 | $32,173 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01DE029510 | Craniofacial microsomia: Accelerating Research and Education (CARE) | 002 | 4 | NIH | 9/11/2023 | $344,041 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01DE029510 | Craniofacial microsomia: Accelerating Research and Education (CARE) | 001 | 4 | NIH | 2/22/2023 | $75,181 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01MH118313 | 1/2 Treating Mothers with ADHD and their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial | 000 | 5 | NIH | 7/19/2023 | $661,289 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 Sand Point Way NE | Seattle | WA | 98105-3916 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 03 | 6 | HRSA | 9/21/2023 | $115,171 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 Sand Point Way NE | Seattle | WA | 98105-3916 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 03 | 6 | HRSA | 9/21/2023 | $188,275 |
| | 2023 | 2023 | Seattle Children's Hospital | 4800 Sand Point Way NE | Seattle | WA | 98105-3916 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 6 | HRSA | 12/14/2022 | $468,486 |
| | 2023 | 2023 | Seattle Children's Hospital | 4800 Sand Point Way NE | Seattle | WA | 98105-3916 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 6 | HRSA | 12/14/2022 | $795,812 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 Sand Point Way NE | Seattle | WA | 98105-3916 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 6 | HRSA | 3/2/2023 | $1,579,494 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 Sand Point Way NE | Seattle | WA | 98105-3916 | KING | USA | T2331575 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 6 | HRSA | 3/2/2023 | $2,683,058 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01HD090230 | Optimizing Collaborative Care for Youth with Persistent Post-Concussive Symptoms | 001 | 5 | NIH | 7/18/2023 | $0 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01HD090230 | Optimizing Collaborative Care for Youth with Persistent Post-Concussive Symptoms | 000 | 5 | NIH | 7/7/2023 | $781,921 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01NS072129 | Mechanisms of synapse formation and axon termination in C. elegans | 000 | 14 | NIH | 6/14/2023 | $619,993 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01DK131134 | Kids CoLab - Supporting collaborative decision making with youth impacted by chronic kidney disease | 000 | 2 | NIH | 6/23/2023 | $627,190 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R37CA266777 | The IL-18-IFN? axis predicts response to immunotherapy | 000 | 1 | NIH | 1/27/2023 | $845,823 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01DE032663 | Influence of viral and immune interventions on early events following oral SIV infection | 000 | 1 | NIH | 1/12/2023 | $837,728 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 Sand Point Way NE | Seattle | WA | 98105-3916 | KING | USA | U01IP001157 | IP21-002, Enhanced Surveillance to Assess Vaccine Preventable Enteric and Respiratory Virus Illnesses | 00 | 3 | CDC | 8/23/2023 | $78,857 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 Sand Point Way NE | Seattle | WA | 98105-3916 | KING | USA | U01IP001157 | IP21-002, Enhanced Surveillance to Assess Vaccine Preventable Enteric and Respiratory Virus Illnesses | 00 | 3 | CDC | 8/23/2023 | $1,549,741 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 Sand Point Way NE | Seattle | WA | 98105-3916 | KING | USA | U01IP001157 | IP21-002, Enhanced Surveillance to Assess Vaccine Preventable Enteric and Respiratory Virus Illnesses | 00 | 3 | CDC | 8/23/2023 | $621,400 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 Sand Point Way NE | Seattle | WA | 98105-3916 | KING | USA | U01IP001157 | IP21-002, Enhanced Surveillance to Assess Vaccine Preventable Enteric and Respiratory Virus Illnesses | 00 | 3 | CDC | 8/23/2023 | $499,996 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | P01HD104435 | Open-source Software Development Supplement for 3D quantitative analysisof mouse models of structural birth defects through computational anatomy | 000 | 3 | NIH | 12/21/2022 | $1,443,563 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R21DC018341 | Transcriptome-driven inference of adverse drug interactions | 000 | 3 | NIH | 12/20/2022 | $167,400 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01FD006848 | A Phase 1b, Multi-center Study of IV Gallium Nitrate in Patients with Cystic Fibrosis who are colonized with Nontuberculosis Mycobacterium (The ABATE Study). | 000 | 2 | FDA | 7/19/2023 | $716,405 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | U19AI128914 | Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization | 003 | 8 | NIH | 5/15/2023 | $600,000 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01ES025169 | TIDES III: Endocrine Disruption, Hormones, and Sex Differences in Adolescent Airway Health | 000 | 7 | NIH | 5/25/2023 | $1,256,380 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | U01CA281848 | Bispecific Antibody Therapeutics for Neuroblastoma and Diffuse Midline Glioma | 000 | 1 | NIH | 7/21/2023 | $860,018 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AG081840 | Pericyte control of capillary perfusion in the Alzheimer's disease brain | 000 | 1 | NIH | 4/4/2023 | $890,037 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | F32NS127946 | Defining the cell type-specific role of miR-9-2 in telencephalon development | 000 | 1 | NIH | 4/17/2023 | $2,500 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | K23HD107232 | A Novel Photo-Narrative Communication Intervention Among Parents of Children with Severe Neurological Impairment in the ICU | 000 | 2 | NIH | 5/22/2023 | $160,131 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | K22CA262343 | Elucidating the role of Ybx1 in cerebellar development and medulloblastoma | 000 | 2 | NIH | 1/24/2023 | $187,056 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R21DC018341 | Transcriptome-driven inference of adverse drug interactions | 001 | 3 | NIH | 1/18/2023 | $18,600 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AI153087 | Viral and immune kinetics in rhinovirus infection following hematopoietic cell transplantation | 000 | 4 | NIH | 5/25/2023 | $768,075 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | U01AI142001 | Assessing the determinants of durable protective immunity in SARS-CoV-2 infected human subjects | 000 | 5 | NIH | 12/12/2022 | $802,689 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | U19AI128914 | Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization | 003 | 8 | NIH | 5/15/2023 | $1,500,000 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01HS029142 | Development and Evaluation of an Instrument to Measure Shared Decision-Making in Pediatrics | 000 | 1 | AHRQ | 7/26/2023 | $395,990 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01HL166317 | Unraveling a parabrachial circuit for the state-dependent control of rapid breathing | 000 | 1 | NIH | 12/30/2022 | $746,089 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01HD106628 | Supraphysiologic Shear Stresses Associated with Cardiopulmonary Bypass are Sufficient to Activate RIKP3 Signaling | 000 | 2 | NIH | 2/23/2023 | $801,557 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01MH123442 | Advancing Suicide Intervention Strategies for Teens During High Risk Periods | 000 | 3 | NIH | 5/31/2023 | $1,281,248 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R37NS095733 | Pathological Mechanisms of Human Cerebellar Malformations | 000 | 8 | NIH | 7/11/2023 | $787,905 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AI155536 | Structural Analysis and Inhibitor Optimization of Cryptosporidium n-myristoyltransferase for Drug Discovery | 000 | 3 | NIH | 11/1/2022 | $829,484 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AI158159 | Dual Targeting of Mtb Resistance Mechanisms | 000 | 4 | NIH | 8/4/2023 | $796,912 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AG062738 | Pericyte structural plasticity and cerebrovascular health | 000 | 4 | NIH | 2/15/2023 | $562,068 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AG062738 | Pericyte structural plasticity and cerebrovascular health | 001 | 4 | NIH | 2/23/2023 | $112,893 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | K01HG010361 | Respect for Persons in the Genomics Research Enrollment Process: Incorporating Diverse Experiences and Attitudes | 001 | 5 | NIH | 12/21/2022 | $124,817 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | U19AI128914 | Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization | 004 | 8 | NIH | 6/16/2023 | $0 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01DK098466 | Brain systems and behaviors underlying response to obesity treatment in children | 000 | 9 | NIH | 8/11/2023 | $656,880 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01DK135211 | Phentermine/Topiramate in children, adolescents, and young adults with hypothalamic obesity: a pilot and feasibility study | 001 | 1 | NIH | 9/7/2023 | $0 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01ES033785 | DiversitySupp-ONES-Prenatal Phthalate Exposure | 001 | 1 | NIH | 8/15/2023 | $29,421 |
| | 2023 | 2023 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | K99CA267481 | Addressing Social Needs of Adolescents and Young Adults (AYAs) with Cancer | 001 | 2 | NIH | 9/6/2023 | $0 |
|
